Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): Randomised controlled trial

BMJ (Online)

Volumn 354, Issue , 2016, Pages

  Leonardi, Sergio ^a   Frigoli, Enrico ^b   Rothenbühler, Martina ^c   Navarese, Eliano ^d   Calabró, Paolo ^e   Bellotti, Paolo ^f   Briguori, Carlo ^g   Ferlini, Marco ^a   Cortese, Bernardo ^h   Lupi, Alessandro ⁱ   Lerna, Salvatore ^j   Zavallonito Parenti, Dennis ^k   Esposito, Giovanni ^l   Tresoldi, Simone ^m   Zingarelli, Antonio ⁿ   Rigattieri, Stefano ^o   Palmieri, Cataldo ^p   Liso, Armando ^q   Abate, Fabio ^r   Zimarino, Marco ^s   Comeglio, Marco ^t   Gabrielli, Gabriele ^u   Chieffo, Alaide ^v   Brugaletta, Salvatore ^w   Mauro, Ciro ^x   Van Mieghem, Nicolas M ^y   Heg, Dik ^c   Jüni, Peter ^z   Windecker, Stephan ^aa   Valgimigli, Marco ^aa   more..

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b EUSTRATEGY Association   (Italy)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF MILAN   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f VILLA SCASSI HOSPITAL   (Italy)

^g Clinica Mediterranea   (Italy)

^h Ospedale Fate Bene Fratelli   (Italy)

ⁱ University Hospital Maggiore della Carita   (Italy)

^j Sirai Hospital   (Italy)

^k HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^l UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^m A O Ospedale di Desio   (Italy)

ⁿ UNIVERSITY OF GENOA   (Italy)

^o SANDRO PERTINI HOSPITAL   (Italy)

^p G PASQUINUCCI HOSPITAL   (Italy)

^q Citta di Lecce Hospital   (Italy)

^r Ospedale Giovanni Paolo II   (Italy)

^s UNIVERSITY OF CHIETI   (Italy)

^t San Jacopo Hospital   (Italy)

^u OSPEDALI RIUNITI   (Italy)

^v SAN RAFFAELE HOSPITAL   (Italy)

^w HOSPITAL CLÍNIC   (Spain)

^x CARDARELLI HOSPITAL   (Italy)

^y ERASMUS MEDICAL CENTER   (Netherlands)

^z ST MICHAEL'S HOSPITAL   (Canada)

^aa BERN UNIVERSITY HOSPITAL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84995747091     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i4935     Document Type: Article

References (19)

1. Shahzad A, Kemp I, Mars C, et al. HEAT-PPCI trial investigators. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial. Lancet 2014;384:1849-58. doi:10.1016/S0140-6736(14)60924-7.
2. Stone GW, Witzenbichler B, Guagliumi G, et al. HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358:2218-30. doi:10.1056/NEJMoa0708191.
3. Kastrati A, Neumann FJ, Schulz S, et al. ISAR-REACT 4 Trial Investigators. Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction. N Engl J Med 2011;365:1980-9. doi:10.1056/NEJMoa1109596.
4. Stone GW, McLaurin BT, Cox DA, et al. ACUITY Investigators. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006;355:2203-16. doi:10.1056/NEJMoa062437.
5. Valgimigli M. MATRIX investigators. Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX program. Am Heart J 2014;168:838-45.e6. doi:10.1016/j.ahj.2014.08.013.
6. Valgimigli M, Frigoli E, Leonardi S, et al. MATRIX Investigators. Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes. N Engl J Med 2015;373:997-1009. doi:10.1056/NEJMoa1507854.
7. De Luca L, Leonardi S, Cavallini C, et al. EYESHOT Investigators. Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study. Eur Heart J Acute Cardiovasc Care 2015;4:441-52. doi:10.1177/2048872614560505.
8. Cavender MA, Sabatine MS. Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials. Lancet 2014;384:599-606. doi:10.1016/S0140-6736(14)61216-2.
9. Valgimigli M, Gagnor A, Calabró P, et al. MATRIX Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet 2015;385:2465-76. doi:10.1016/S0140-6736(15)60292-6.
10. Nikus K, Pahlm O, Wagner G, et al. Electrocardiographic classification of acute coronary syndromes: a review by a committee of the International Society for Holter and Non-Invasive Electrocardiology. J Electrocardiol 2010;43:91-103. doi:10.1016/j.jelectrocard.2009.07.009.
11. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011;123:2736-47. doi:10.1161/CIRCULATIONAHA.110.009449.
12. GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med 1993;329:673-82. doi:10.1056/NEJM199309023291001.
13. Clayton D, Hills M. Statistical models in epidemiology.Oxford University Press, 1993.
14. Dangas GD, Mehran R, Nikolsky E, et al. HORIZONS-AMI Trial Investigators. Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis. J Am Coll Cardiol 2011;57:2309-16. doi:10.1016/j.jacc.2011.01.038.
15. Koutouzis M, Lagerqvist B, James S, et al. Unfractionated heparin administration in patients treated with bivalirudin during primary percutaneous coronary intervention is associated lower mortality and target lesion thrombosis: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Heart 2011;97:1484-8. doi:10.1136/hrt.2011.224709.
16. White HD, Chew DP, Hoekstra JW, et al. Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol 2008;51:1734-41. doi:10.1016/j.jacc.2007.12.052.
17. Saltzman AJ, Stone GW, Claessen BE, et al. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv 2011;4:1011-9. doi:10.1016/j.jcin.2011.06.012.
18. Chew DP, Bhatt DL, Kimball W, et al. Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials. Am J Cardiol 2003;92:919-23. doi:10.1016/S0002-9149(03)00970-6.
19. Franchi F, Angiolillo DJ. Novel antiplatelet agents in acute coronary syndrome. Nat Rev Cardiol 2015;12:30-47. doi:10.1038/nrcardio.2014.156.